Trial Investigating COVID-19 Therapy in Long-Term Care Facilities Begins
The BLAZE-2 trial is being conducted in collaboration with the NIAID and the COVID-19 Prevention Network.
COVID19
Telemedicine Use Explodes During COVID-19 Pandemic
Two experts spdoke with HD Live! about telemedicine’s growth, best practices, outlook for the future
US Puts Up Another $2.1 Billion for Potential COVID-19 Vaccine
GlaxoSmithKline and Sanofi Pasteur will supply 100 million doses of its experimental vaccine to the US.
Plenty of COVID-19 Vaccine Coming, Fauci Says
To combat the surging pandemic, Fauci is calling on all Americans to practice social distancing and wearing masks.
Intravenous Vitamin C Linked to Early Recovery in Critically Ill COVID-19 Patient
The patient, a 74-year-old female, presented to the ER after experiencing a low grade fever, cough, and shortness of breath for 2 days.
MPR Weekly Dose Podcast Episode 45
It’s been an important week with big developments in potential COVID-19 vaccines; News on how steroid therapy may help some COVID patients; There’s results from the Actemra trial in COVID pneumonia patients; News that sputum samples may be just as effective as nasopharyngeal samples for detecting SARS-CVv-2; And researchers have linked vaccination to reduced risks of Alzheimer disease.
Young Children Have Higher Amounts of SARS-CoV-2 RNA
Children younger than 5 years have lower median cycle threshold values compared with older children, adults
No Benefit With Tocilizumab in COVID-19 Pneumonia Trial
A phase 3 study of tocilizumab (Actemra®) for the treatment of hospitalized patients with severe COVID-19 pneumonia did not meet its primary and key secondary end points.
COVID-19 Vaccine Candidate Provides Protection in Animal Challenge Study
Vaccination with mRNA-1273, Moderna’s coronavirus disease 2019 (COVID-19) vaccine candidate, led to robust immune responses and protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in nonhuman primates.
Respiratory Sampling Strategies for Detecting SARS-CoV-2 Compared
Sputum sampling was found to be a valuable method for diagnosing and monitoring patients with coronavirus disease 2019 (COVID-19), according to a recent systematic review and meta-analysis published in EBioMedicine.
